18F-FDG PET/CT 评估移植后淋巴增殖性疾病
移植后淋巴增殖性疾病(PTLD)是实体器官或异基因造血干细胞移植后的严重并发症,多与免疫抑制下B细胞EB病毒再激活相关。组织活检是确诊和分型的关键,而18F-FDG PET/CT在检测、分期和疗效评估中显示出高敏感性和特异性,但尚需更大规模多中心前瞻性验证。PET/MR等新型混合成像可能有助于减少辐射暴露,对儿童移植患者尤为重要。
要点
- PTLD是移植后严重并发症,多与EB病毒再激活相关。
- 组织活检是确诊和分型的关键,指导治疗选择。
- 18F-FDG PET/CT在检测、分期和疗效评估中显示高敏感性及特异性。
核心结论
- 18F-FDG PET/CT在PTLD检测、分期和疗效评估中显示高敏感性和特异性,但尚需更大规模多中心前瞻性验证。
研究设计与样本
- 综述性文章,总结近二十年多项临床研究中18F-FDG PET/CT在PTLD管理中的应用证据。
主要发现
- PTLD是一组异质性淋巴增殖性疾病,为实体器官或异基因造血干细胞移植后的严重、可能致命并发症。
- 多数PTLD归因于移植后免疫抑制状态下B细胞中EB病毒再激活。
- 18F-FDG PET/CT在PTLD检测、分期和疗效评估中显示高敏感性和特异性。
- PET/MR等新型混合成像可能有助于减少辐射暴露,对儿童移植患者尤为重要。
临床怎么用
- 组织活检和病理分析是确诊PTLD及确定亚型的必要手段,以指导治疗选择。
- 18F-FDG PET/CT可用于PTLD的检测、分期和疗效评估。
- 儿童移植患者可考虑PET/MR等混合成像以减少辐射暴露。
局限性
- 尚需更大规模多中心前瞻性验证以进一步确立PET成像在PTLD管理中的临床效用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Post-transplant lymphoproliferative disorders (PTLD) are a spectrum of heterogeneous lymphoproliferative conditions that are serious and possibly fatal complications after solid organ or allogenic hematopoietic stem cell transplantation. Most PTLD are attributed to Epstein-Barr virus reactivation in B-cells in the setting of immunosuppression after transplantation. Early diagnosis, accurate staging, and timely treatment are of vital importance to reduce morbidity and mortality. Given the often nonspecific clinical presentation and disease heterogeneity of PTLD, tissue biopsy and histopathological analysis are essential to establish diagnosis and most importantly, determine the subtype of PTLD, which guides treatment options. Advanced imaging modalities such as 18F-FDG PET/CT have played an increasingly important role and have shown high sensitivity and specificity in detection, staging, and assessing treatment response in multiple clinical studies over the last two decades. However, larger multicenter prospective validation is still needed to further establish the clinical utility of PET imaging in the management of PTLD. Significantly, new hybrid imaging modalities such as PET/MR may help reduce radiation exposure, which is especially important in pediatric transplant patients.
引用
- Song H, Guja KE, Iagaru A, et al. 18F-FDG PET/CT for Evaluation of Post-Transplant Lymphoproliferative Disorder (PTLD). Semin Nucl Med. 2021. PMID: 33455722. doi:10.1053/j.semnuclmed.2020.12.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。